News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
RA CAPITAL MANAGEMENT, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 4.6% stake in SOLENO THERAPEUTICS, INC. |
| 09/29/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.3% stake in CHIMERIX, INC. |
| 08/25/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in TAYSHA GENE THERAPIES, INC. |
| 08/21/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in GRACELL BIOTECHNOLOGIES INC. |
| 08/17/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 9.8% stake in NEKTAR THERAPEUTICS |
| 07/06/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.5% stake in TALARIS THERAPEUTICS, INC. |
| 07/06/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in UNICYCIVE THERAPEUTICS, INC. |
| 03/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.3% stake in HILLEVAX, INC. |
| 02/14/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.4% stake in Orchestra Biomed Holdings, Inc. |
| 12/30/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 8.2% stake in AVIDITY BIOSCIENCES, INC. |
| 12/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/24/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 12.2% stake in IMARA, INC. |
| 10/17/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 8.2% stake in INHIBRX, INC. |
| 10/17/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.5% stake in ADICET BIO, INC. |
| 10/13/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.3% stake in DESIGN THERAPEUTICS, INC. |
| 10/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 6.1% stake in MAGENTA THERAPEUTICS, INC. |
| 09/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 8.6% stake in THIRD HARMONIC BIO, INC. |
| 09/06/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.5% stake in COGENT BIOSCIENCES, INC. |
| 08/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 13.4% stake in FULCRUM THERAPEUTICS, INC. |
| 06/22/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.9% stake in INSTIL BIO, INC. |
| 05/25/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 9.9% stake in CELCUITY INC. |
| 04/28/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.7% stake in NANOSTRING TECHNOLOGIES, INC. |
| 04/25/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.1% stake in ACLARIS THERAPEUTICS, INC. |
| 04/21/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 9.9% stake in VERU INC. |
| 04/08/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 19.6% stake in AN2 THERAPEUTICS, INC. |
| 03/24/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 6% stake in FLUIDIGM CORP. |
| 02/24/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.5% stake in VERA THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.3% stake in EDGEWISE THERAPEUTICS, INC. |
| 01/10/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.1% stake in Pardes Biosciences, Inc. |
| 12/22/2021 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 9.9% stake in Bellus Health Inc. |
| 12/20/2021 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.2% stake in Relmada Therapeutics, Inc. |
|
|
|